Clinical Trial Update: Study on Human Bioequivalence of Triprerelin Acetate for Injection [Phase 1]

View source ↗

Summary

A Phase 1 human bioequivalence study of Triprerelin Acetate for Injection is currently recruiting in patients with castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Triprerelin Acetate for Injection (triprerelin acetate)

Snippet

Sponsor: The Affiliated Hospital of Qingdao University | Conditions: Prostate Cancer (CRPC) | Phase 1 | Status: RECRUITING